CJC-1295
$390.00
CJC-1295 is a synthetic peptide and growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to release natural growth hormone (GH). It is designed with a long half-life through Drug Affinity Complex (DAC) technology, allowing for sustained GH release and fewer injections. CJC-1295 is widely studied for its effects on muscle growth, fat loss, recovery, sleep quality, and anti-aging. Often stacked with peptides like Ipamorelin, CJC-1295 is popular in research focused on performance enhancement, hormone optimization, and tissue repair. You can buy CJC-1295 online from trusted peptide suppliers for research use.
Key Benefits
- Increased Growth Hormone Production – Stimulates natural GH secretion to support body composition and performance.
- Fat Loss – Enhances lipolysis (fat breakdown) through elevated GH and IGF-1 levels.
- Muscle Growth & Repair – Promotes protein synthesis and cellular regeneration in muscles and tissues.
- Improved Sleep Quality – Associated with deeper, more restorative sleep by influencing GH pulses during REM cycles.
- Anti-Aging Effects – May reduce wrinkles, improve skin elasticity, and support overall vitality through growth hormone pathways.
Mechanism of Action
- CJC-1295 is a modified GHRH (1-29) analog with DAC, extending its half-life to around 1– 2 weeks.
- It binds to albumin in the bloodstream, allowing sustained stimulation of the pituitary gland to release growth hormone.
- This results in natural GH secretion, which then promotes IGF-1 production — a key factor in tissue growth and repair.
Dosage Recommendations
- Typical Dosage – 1–2 mg per injection, once or twice weekly for DAC form; daily for non- DAC versions.
- Administration – Subcutaneous injection is the most common route in research settings.
- Cycling – Often used in 8–12 week cycles, with breaks to allow for hormonal balance restoration.
Research and Studies
- Studies have shown that CJC-1295 significantly increases both GH and IGF-1 levels without desensitizing the pituitary gland.
- Research indicates improved recovery time, lean muscle gain, and decreased fat mass in experimental models.
- Its extended half-life makes it more convenient than daily GHRH peptides like Sermorelin.
Possible Side Effects and Contraindications
- Common Side Effects – Mild water retention, tingling, increased appetite, or injection site irritation.
- Precautions – Not advised for individuals with active cancers due to GH/IGF-1’s potential to stimulate cell growth.
- Drug Interactions – May amplify the effects of other GH secretagogues like Ipamorelin or GHRP-6; monitor stacked protocols carefully.
Storage and Handling Instructions
- Store reconstituted CJC-1295 in a refrigerator at 2–8°C (36–46°F).
- Lyophilized powder should be stored in a cool, dark location prior to mixing.
- Avoid contamination by using sterile techniques and proper handling tools.
Frequently Asked Questions (FAQs)
- What’s the difference between CJC-1295 with DAC and without DAC?
DAC extends the peptide’s half-life to days, while the non-DAC version requires more frequent dosing for shorter GH pulses.
- Can it be stacked with other peptides?
Yes, CJC-1295 is commonly stacked with Ipamorelin or GHRP-2 for synergistic growth hormone release.
- When do results typically appear?
Results may begin to appear after 3–4 weeks of consistent use, with improvements in sleep, recovery, and fat loss.
Medical Disclaimer
CJC-1295 is intended for research and educational purposes only. It is not approved for human consumption or to diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any research protocol.